Lupin intros generic Methergine tablets
Lupin has launched its generic Methergine tablets (methylergonovine), having previously received approval from the Food and Drug Administration. The drug is indicated to treat and prevent postpartum hemorrhage.
Lupin’s generic Methergine tablets will be available in 0.2-mg dosage strength. The product’s market size was $71.5 million for the 12 months ended April 2018, according to IQVIA data.
Lupin’s generic Methergine tablets will be available in 0.2-mg dosage strength. The product’s market size was $71.5 million for the 12 months ended April 2018, according to IQVIA data.